...
qncx-img

Quince Therapeutics, Inc., Common Stock

QNCX

NSQ

$1.935

+$0.09

(4.89%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$71.84M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
100.66K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.71
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.51 L
$2.45 H
$1.935

About Quince Therapeutics, Inc., Common Stock

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising EryKit, Syringe Kit, drugs, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameQNCXSectorS&P500
1-Week Return-6.6%-3.39%0.2%
1-Month Return5.14%-1.92%2.72%
3-Month Return143.71%-10.54%7.31%
6-Month Return159.15%-4.47%10.44%
1-Year Return68.04%4.06%27.53%
3-Year Return-84.88%0.94%30.88%
5-Year Return-95.64%36.67%89.21%
10-Year Return-94.41%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue188.00K332.00K344.00K175.00K322.00K[{"date":"2019-12-31","value":54.65,"profit":true},{"date":"2020-12-31","value":96.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.87,"profit":true},{"date":"2023-12-31","value":93.6,"profit":true}]
Gross Profit(188.00K)(332.00K)(344.00K)(175.00K)(322.00K)[{"date":"2019-12-31","value":-18800000,"profit":false},{"date":"2020-12-31","value":-33200000,"profit":false},{"date":"2021-12-31","value":-34400000,"profit":false},{"date":"2022-12-31","value":-17500000,"profit":false},{"date":"2023-12-31","value":-32200000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses39.17M78.89M90.32M51.19M34.62M[{"date":"2019-12-31","value":43.37,"profit":true},{"date":"2020-12-31","value":87.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":56.68,"profit":true},{"date":"2023-12-31","value":38.33,"profit":true}]
Operating Income(39.17M)(78.89M)(90.32M)(52.02M)(34.62M)[{"date":"2019-12-31","value":-3916800000,"profit":false},{"date":"2020-12-31","value":-7889300000,"profit":false},{"date":"2021-12-31","value":-9031800000,"profit":false},{"date":"2022-12-31","value":-5201500000,"profit":false},{"date":"2023-12-31","value":-3462000000,"profit":false}]
Total Non-Operating Income/Expense4.38M4.09M993.00K1.14M6.04M[{"date":"2019-12-31","value":72.47,"profit":true},{"date":"2020-12-31","value":67.7,"profit":true},{"date":"2021-12-31","value":16.45,"profit":true},{"date":"2022-12-31","value":18.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(36.98M)(76.85M)(89.94M)(51.94M)(31.58M)[{"date":"2019-12-31","value":-3698000000,"profit":false},{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8994500000,"profit":false},{"date":"2022-12-31","value":-5194400000,"profit":false},{"date":"2023-12-31","value":-3158200000,"profit":false}]
Income Taxes(188.00K)2.17M(620.00K)(284.00K)(197.00K)[{"date":"2019-12-31","value":-8.66,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-28.58,"profit":false},{"date":"2022-12-31","value":-13.09,"profit":false},{"date":"2023-12-31","value":-9.08,"profit":false}]
Income After Taxes(36.79M)(79.02M)(89.33M)(51.66M)(31.39M)[{"date":"2019-12-31","value":-3679200000,"profit":false},{"date":"2020-12-31","value":-7901870300,"profit":false},{"date":"2021-12-31","value":-8932500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-3138500000,"profit":false}]
Income From Continuous Operations(36.98M)(76.85M)(89.94M)(51.66M)(28.02M)[{"date":"2019-12-31","value":-3698000000,"profit":false},{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8994500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-2802500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(36.79M)(76.85M)(89.33M)(51.66M)(31.39M)[{"date":"2019-12-31","value":-3679200000,"profit":false},{"date":"2020-12-31","value":-7684900000,"profit":false},{"date":"2021-12-31","value":-8932500000,"profit":false},{"date":"2022-12-31","value":-5166000000,"profit":false},{"date":"2023-12-31","value":-3138500000,"profit":false}]
EPS (Diluted)(2.90)(2.63)(3.03)(1.60)(0.85)[{"date":"2019-12-31","value":-290,"profit":false},{"date":"2020-12-31","value":-263,"profit":false},{"date":"2021-12-31","value":-303,"profit":false},{"date":"2022-12-31","value":-160,"profit":false},{"date":"2023-12-31","value":-84.61,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

QNCX
Cash Ratio 8.82
Current Ratio 9.53

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNCX
ROA (LTM) -16.50%
ROE (LTM) -79.38%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNCX
Debt Ratio Lower is generally better. Negative is bad. 0.64
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.36

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNCX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.80
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.44

FAQs

What is Quince Therapeutics, Inc. share price today?

Quince Therapeutics, Inc. (QNCX) share price today is $1.935

Can Indians buy Quince Therapeutics, Inc. shares?

Yes, Indians can buy shares of Quince Therapeutics, Inc. (QNCX) on Vested. To buy Quince Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNCX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quince Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Quince Therapeutics, Inc. (QNCX) via the Vested app. You can start investing in Quince Therapeutics, Inc. (QNCX) with a minimum investment of $1.

How to invest in Quince Therapeutics, Inc. shares from India?

You can invest in shares of Quince Therapeutics, Inc. (QNCX) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNCX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quince Therapeutics, Inc. shares
What is Quince Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Quince Therapeutics, Inc. (QNCX) is $2.45. The 52-week low price of Quince Therapeutics, Inc. (QNCX) is $0.51.

What is Quince Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quince Therapeutics, Inc. (QNCX) is

What is Quince Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quince Therapeutics, Inc. (QNCX) is 1.80

What is Quince Therapeutics, Inc. dividend yield?

The dividend yield of Quince Therapeutics, Inc. (QNCX) is 0.00%

What is the Market Cap of Quince Therapeutics, Inc.?

The market capitalization of Quince Therapeutics, Inc. (QNCX) is $71.84M

What is Quince Therapeutics, Inc.’s stock symbol?

The stock symbol (or ticker) of Quince Therapeutics, Inc. is QNCX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top